Two Therapies Prove Effective Treating Hospitalized COVID-19 Patients


From  –  Early COVID Treatment Works

This study points to a more effective therapeutic treatment using a combination of Ivermectin and Doxycycline.  In the study, the therpy was able to produce effective results for both the use of Ivermectin-Doxycycline  and Hydroxychloroquine-Azithromycin, with the former combination outperforming the latter (the former being from Group B).

A Comparative Study on Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin Therapy on COVID-19 Patients, Abu Taiub Mohammed Mohiuddin Chowdhury, Mohammad Shahbaz, Md Rezaul Karim, Jahirul Islam, Guo Dan, Shuixiang He

Results: All subjects in Group A reached a negative PCR, at a mean of 8.93 days, and reached symptomatic recovery, at a
mean of 5.93 days, with 55.10% symptom-free by the fifth day. In group B, 96.36% reached a negative PCR at a mean of
9.33 days and were symptoms-free at 6.99 days. In group A 31.67% of patients expressed symptoms caused by medication, this was 46.43% in group B.
Conclusion: The combination therapy of Ivermectin-Doxycycline showed a trend towards superiority to the combination of Hydroxychloroquine-Azithromycin for mild to moderate COVID19 disease.

Read the Full Study

More Evidence

Sign the Declaration

Leave a Reply

Your email address will not be published. Required fields are marked *